“Capmatinib in Patients With MET-Positive Advanced Non-Small Cell Lung Cancer: Analysis of the Russian Cohort in the Geometry Mono-1 Study”. 2022. Voprosy Onkologii 68 (6): 758-67. https://doi.org/10.37469/0507-3758-2022-68-6-758-767.